Cereblon as a Predictive Biomarker for Imid Therapy Sensitivity

Adel Gouri2* , Amel Bouacha1, Aoulia Dekaken3, Faiza Mehiddine4, Ahmed Aimen Bentorki2, Amina Yakhlef5 and Mehdi Beleilli6 1Department of Hematology, IBN ROCHD Public Hospital, Souk Ahras 41000, Algeria 2Laboratory of Medical Biochemistry, IBN ZOHR Public Hospital, Guelma 24000, Algeria 3Department of Internal Medicine; Pr EL OKBI Public Hospital, Guelma 24000, Algeria 4Department of Pneumology, IBN ZOHR Public Hospital, Guelma 24000, Algeria 5Department of Hematology, IBN ZOHR Public Hospital, Guelma 24000, Algeria 6Laboratory of Pharmaceutical Chemistry, College of Medicine, Annaba 2300, Algeria *Corresponding author: Adel Gouri, Laboratory of Medical Biochemistry, IBN ZOHR Public Hospital, Guelma 24000, Algeria, Tel: 00213 666 088 ; E-mail: pharmagor@gmail.com